Acquisition

June 29, 2026 To To The Secretary, The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd, 1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051. Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/ Madam, Sub: Intimation of acquisition of 3,57,143 Optionally Convertible Redeemable Preference Shares in Alfaone Medicals Private Limited, an associate company of Aster DM Healthcare Limited (“Company”) Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Regulation 30 of the SEBI Listing Regulations, this is to inform you that the Company, today i.e., June 29, 2026, has acquired 3,57,143 Optionally Convertible Redeemable Preference Shares (OCRPS) of face value of Rs. 10/- each at price of Rs. 700/- each including security premium of Rs. 690/- each, by subscribing in rights issue of Alfaone Medicals Private Limited, an associate company of the Company. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are given in “Annexure I”. The above-mentioned information will also be available on the website of the Company at https://www.asterdmhealthcare.in. We request you to kindly take the above information on record. Thank you For Aster DM Healthcare Limited Hemish Purushottam Company Secretary and Compliance Officer M. No: A24331 Annexure I Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1 Name of the target entity, details in brief Name: Alfaone Medicals Private Limited. (“AMPL”) such as size, turnover etc. Date of incorporation: December 03, 2020 Authorized Share Capital: Rs. 6,36,94,690/- (Rupees Six Crore Thirty-Six Lakh Ninety-Four Thousand Six Hundred and Ninety Only) comprising 24,22,369 equity shares of face value of Rs. 10/- each and 39,47,100 Optionally Convertible Redeemable Preference Shares of face value of Rs. 10/- each. Paid-up Share Capital: Rs. 5,75,00,410/- (Rupees Five Crore Seventy-Five Lakh Four Hundred and Ten Only) comprising 23,52,941 equity shares of face value of Rs.10/- each and 3,397,100 Optionally Convertible Redeemable Preference Shares (‘OCRPS’) of face value of Rs. 10/- each. Turnover: For the financial year ended 31 March 2026: Rs 589.55 lakhs. 2 Whether the acquisition would fall within AMPL being an associate Company, is a related party related party transaction(s) and whether of the Company. The transaction falls within the the promoter/ promoter group/ group ambit of related party transactions. The Board has companies have any interest in the entity approved the related party transaction. being acquired? If yes, nature of interest Apart from the aforesaid, the promoter / promoter and details thereof and whether the same group/ group companies do not have any interest in is done at “arm’s length” AMPL. The transaction is done at an arm’s length basis. Sr. Particulars Details 3 Industry to which the entity being Healthcare Industry acquired belongs 4 Objects and impact of acquisition The investment by the Company is being made for (including but not limited to, disclosure of general corporate purposes. reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) 5 Brief details of any governmental or Not Applicable regulatory approvals required for the acquisition; 6 Indicative time period for completion of AMPL has allotted 3,57,143 Optionally Convertible the acquisition; Redeemable Preference Shares of face value of Rs. 10/- each on June 29, 2026. 7 Consideration - whether cash Cash consideration consideration or share swap or any other form and details of the same; 8 Cost of acquisition and/or the price at Rs. 25,00,00,100/- (Rupees Twenty-Five Crore and which the shares are acquired; Hundred Only). OCRPS are acquired at Rs. 700/- each (Rupees Seven Hundred Only). 9 Percentage of shareholding / control 3,57,143 Optionally Convertible Redeemable acquired and / or number of shares Preference Shares of face value of Rs.10/- each acquired at Rs. 700/- each including security acquired; premium of Rs. 690/- each. Pre-Acquisition: Number and Percentage of Equity Shares: 11,50,941 (48.91%) Number and Percentage of OCRPS: 33,97,100 (100%) Post-Acquisition: Number and Percentage of Equity Shares: 11,50,941 (48.91%) Number and Percentage of OCRPS: 37,54,243 (100%) 10 Brief background about the entity AMPL has been incorporated on December 03, 2020, acquired in terms of products/line of in Bengaluru, Karnataka, India, inter alia, to carry on business acquired, date of incorporation, the business of trading drugs and pharmaceuticals. history of last 3 years turnover, country in Turnover: which the acquired entity has presence and any other significant information (in FY2025-26: Rs. 589.55 lakhs brief); FY2024-25: Rs. 616.32 lakhs FY2023-24: Rs. 621.79 lakhs